UNSPSC 51144131: Dexamfetamine

This classification denotes a cns stimulant with the molecular formula C9H13N, a preparation that US FDA recognizes as an active ingredient or moiety under Unique Ingredient Identifier TZ47U051FI, chemically known as phenethylamine, alpha-methyl-, d- but more generally known as dexamfetamine, which bears U.S. National Institutes of Health Compound Identifier 5826. European Medicines Agency schedules Dexamfetamine in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07019MIG. The term DEXAMFETAMINE is an International Non-Proprietary Name.

World Health Organization schedules dexamfetamine in its Anatomical Therapeutic Chemical (ATC) Classification and its WHO-DD or Drug Dictionary. DEXAMFETAMINE is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix.

UNSPSC 51144131 Dexamfetamine is a Commodity code that nominally addresses pharmaceutical stimulant products, but recent state and local activity shows a significant mismatch between the code's abstract scope and what is actually being procured under it. The single recent opportunity identified—Seminole County, Florida's IFB for naloxone and drug deactivation systems—falls outside the code's stated pharmaceutical category entirely, suggesting either misclassification in the county's procurement system or that this code does not reflect active state and local buying patterns for dexamfetamine or related controlled pharmaceutical stimulants. State and local health departments, counties, and municipalities that do procure such medications typically route them through pharmacy benefits managers, group purchasing organizations, or established cooperative purchasing vehicles rather than direct competitive bidding at the commodity level.

Geographic activity is limited to Florida based on the available record. Seminole County posted IFB60459723LAS on June 30, 2026, seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually with quarterly deliveries to the Seminole County Community Health Building in Sanford, Florida; the bid deadline was July 26, 2023 (note the discrepancy between posting and deadline dates in the source). The contract carries an initial two-year term with a one-year renewal option and requires E-Verify compliance, drug-free workplace certification, and workers' compensation and commercial general liability insurance. No other recent opportunities appear under this code, and the single Seminole County record represents procurement of harm-reduction and emergency-response products rather than dexamfetamine itself, limiting relevance for vendors positioning in the actual stimulant-pharmaceutical space.